Novo Nordisk wins EU approval for higher Wegovy dose
The European Commission has granted final approval for a higher injectable dose of the weight-loss drug Wegovy. The approval allows for a weekly 7.2 mg dose for adults with severe obesity. Previously, the maximum dose in the EU was 2.4 mg. Doctors can now prescribe the 7.2 mg dose as three simultaneous 2.4 mg injections. […]